UP: BHU researchers develop first molecular classification of oral cancer to guide precision therapy
VARANASI: A landmark Indian study, \"Unveiling Oral Cancer’s Molecular Blueprint: A Novel Classification to Guide Precision ...
Computational pathology-informed immune biomarker for trastuzumab benefit in HER2+ breast cancer: Validation in NSABP B-41 clinical trial. Analysis of event-free survival (EFS) of stromal tumor ...
Experts cited by reports stated that this regulation was crucial as it ensures that such emerging technologies are utilised ...
In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...
A Targeted Methylation–Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease This retrospective analysis ...
A UCSF and Gladstone Institutes team discovered a pair of cancer drugs that successfully treated a model of severe Alzheimer’s disease. From left: Marina Sirota, PhD; Yaqiao Li, PhD; and Yadong Huang, ...
With few treatments available to stop or reverse Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of walking back cognitive decline. Alzheimer’s cases are rising in the ...
Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results